Clinical trial NCT04990674: Acute-REMOTION: REMOTION in Acute Psychiatric Care
Official title: Acute-REMOTION: a Randomized Controlled Pilot Trial to Investigate the Feasibility and Potential Effects of a Transdiagnostic Treatment to Reduce Symptom Severity and Improve Emotion Regulation in Acute Psychiatric Patient Care
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Mental Disorder
Lead sponsor: University of Bern
Sponsor class: OTHER
First posted: 2021-08-04
Enrollment: 60
Sex: ALL
Minimum age (years): 18
Maximum age (years): 85
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: This study aims to examine REMOTION, an internet-based intervention aimed at reducing symptom severity and improving emotion regulation in an acute psychiatric inpatient care setting. REMOTION is currently being studied in an outpatient psychotherapy setting. This study aims to investigate feasibility and first effects of this intervention in inpatient psychiatric care.


Eligibility criteria: Inclusion Criteria:

* 18 or older
* In acute inpatient care
* With internet access
* Informed consent given

Exclusion Criteria:

* Current participation in another specific emotion regulation intervention group
* Current or history of psychotic disorders, bipolar disorder, mental retardation or organic mental disorders
* Acute suicidality
* Insufficient mastery of German language

Primary outcomes:
measure: Change in general symptom severity
timeFrame: Assessed at Baseline
measure: Change in general symptom severity
timeFrame: Assessed after 4 weeks
measure: Change in general symptom severity
timeFrame: Assessed after inpatient discharge (on average 24 days after inpatient intake)
measure: Change in general symptom severity
timeFrame: Assessed after 8 weeks
Secondary outcomes:
measure: Difficulties in emotion regulation
timeFrame: Assessed at Baseline, then after 4 Weeks, after inpatient discharge (on average 24 days after inpatient intake), and after 8 Weeks
measure: Emotion regulation skills
timeFrame: Assessed at Baseline, then after 4 Weeks, after inpatient discharge (on average 24 days after inpatient intake), and after 8 Weeks
measure: Usability of REMOTION
timeFrame: Assessed after 4 weeks, after inpatient discharge (on average 24 days after inpatient intake), and after 8 Weeks
measure: Satisfaction with REMOTION
timeFrame: Assessed after 4 Weeks, after inpatient discharge (on average 24 days after inpatient intake), and after 8 Weeks
measure: REMOTION usage parameters
timeFrame: Assessed after 4 weeks, after inpatient discharge (on average 24 days after inpatient intake) and after 8 weeks
measure: Qualitative interviews with healthcare workers
timeFrame: 4 months after study start
measure: Qualitative interviews with patients lost to follow up
timeFrame: After a patient is lost to follow-up (after the 8 week timepoint when follow-up is assessed, has passed for the individual patient)
Other outcomes:
Locations:
city: Bern
country: Switzerland
facility: Universitäre Psychiatrische Dienste Bern
Study officials:
affiliation: Universitäre Psychiatrische Dienste Bern, Universität Bern
name: Franz Moggi, Prof. Dr.
role: PRINCIPAL_INVESTIGATOR
References: